Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hubei Jumpcan Pharmaceutical Co., Ltd.

Why is Hubei Jumpcan Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.92% and Operating profit at 3.26% over the last 5 years

With a fall in PBT of -27.18%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 1,350.62 MM
ROCE(HY) Lowest at 11.84%
INVENTORY TURNOVER RATIO(HY) Lowest at 2.94 times

Underperformed the market in the last 1 year

The stock has generated a return of 2.46% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Hubei Jumpcan Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hubei Jumpcan Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Hubei Jumpcan Pharmaceutical Co., Ltd.

-10.5%

-1.23

22.01%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.48%

EBIT Growth (5y)

6.31%

EBIT to Interest (avg)

81.87

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.76

Sales to Capital Employed (avg)

0.50

Tax Ratio

14.86%

Dividend Payout Ratio

89.72%

Pledged Shares

Institutional Holding

ROCE (avg)

56.77%

ROE (avg)

17.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.69

EV to EBIT

7.62

EV to EBITDA

6.74

EV to Capital Employed

3.97

EV to Sales

2.33

PEG Ratio

Dividend Yield

7.63%

ROCE (Latest)

52.16%

ROE (Latest)

11.35%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -9.13% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -76.95 %

-17What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,472.4 MM

NET SALES(Q)

At CNY 1,207.5 MM has Fallen at -22.33%

ROCE(HY)

Lowest at 11.53%

INTEREST COVERAGE RATIO(Q)

Lowest at 6,177.44

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.51 times

INTEREST(Q)

Highest at CNY 6.17 MM

Here's what is working for Hubei Jumpcan Pharmaceutical Co., Ltd.

Debt-Equity Ratio

Lowest at -76.95 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -9.13% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hubei Jumpcan Pharmaceutical Co., Ltd.

Net Sales

At CNY 1,207.5 MM has Fallen at -22.33%

over average net sales of the previous four periods of CNY 1,554.66 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY 1,472.4 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 6.17 MM has Grown at 203.05%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 6,177.44

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at CNY 6.17 MM

in the last five periods and Increased by 203.05% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 2.51 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio